Putative folding pathway of insulin-like growth factor-1

被引:32
|
作者
Rosenfeld, RD
Miller, JA
Narhi, LO
Hawkins, N
Katta, V
Lauren, S
Weiss, MA
Arakawa, T
机构
[1] Amgen Inc., Amgen Center, Thousand Oaks
[2] Amgen Inc., Amgen Center, 14-2-A-223, Thousand Oaks
关键词
D O I
10.1006/abbi.1997.9996
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Insulin-like growth factor-1 (IGF-I) has three disulfide bonds and refolding of the fully reduced molecule generates varying ratios of correctly (PII) and incorrectly (PI) folded forms via several intermediates, All of the intermediates have the disulfide bond between Cys18 and 61 formed, indicating that formation of this disulfide is the first step in refolding. In order to further understand the refolding pathway, two intermediate forms, PIII with the additional disulfide Cys(6/47) formed and PIIIa with Cys(6/48) formed, were isolated, The oxidation of the remaining Cys48 and 52 in PIII and Cys47 and 52 in PIIIa would lead to PI and PII, respectively; however, air oxidation of these resulted in a rapid reshuffling into other intermediates as well as folding into the fully oxidized forms, and this occurred whether refolding was started with PIII or PIIIa. When oxidation occurred in the presence of an excess of oxidized glutathione, the predominant species generated were various glutathione adducts regardless of the initial intermediate form, indicating that formation of the last disulfide bond is not a favorable process relative to disulfide exchange when excess disulfides from oxidized glutathione are present. Interestingly, if 80 mu M copper sulfate, an oxidant, is added to the refolding buffer, PIII resulted in formation of the PI form alone, whereas PIIIa resulted in the PII form alone. It was concluded from these results that the intermediate forms of IGF-1 can rapidly reshuffle between different disulfide structures, and that formation of the last disulfide bond is not as favorable a process as the conversion to other intermediates, The oxidation to form the last disulfide bond in PIII or PIIIa is accelerated and hence the interconversion to other intermediates is kinetically minimized only in the presence of copper sulfate. It appears, therefore, that the two intermediate forms, PIII and PIIIa, are the precursors of the corresponding fully oxidized forms, but their conversions are not energetically a favorable process. (C) 1997 Academic Press.
引用
收藏
页码:298 / 305
页数:8
相关论文
共 50 条
  • [21] The role of insulin and insulin-like growth factor-1 in mammalian ageing
    Richardson, A
    Liu, F
    Adamo, ML
    Van Remmen, H
    Nelson, JF
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 18 (03) : 393 - 406
  • [22] Insulin-like growth factor-1 is a growth promoting factor for Leishmania promastigotes
    Gomes, CMC
    Goto, H
    Corbett, CEP
    Gidlund, M
    ACTA TROPICA, 1997, 64 (3-4) : 225 - 228
  • [23] Insulin, insulin-like growth factor-1, insulin receptor, and insulin-like growth factor-1 receptor expression in the chick eye and their regulation with imposed myopic or hyperopic defocus
    Penha, Alexandra Marcha
    Schaeffel, Frank
    Feldkaemper, Marita
    MOLECULAR VISION, 2011, 17 (162): : 1436 - 1448
  • [24] Insulin and insulin-like growth factor-1 action on human skeletal muscle: Preferential effects of insulin-like growth factor-1 in type 2 diabetic subjects
    Ciaraldi, TP
    Carter, L
    Rehman, N
    Mohideen, P
    Mudaliar, S
    Henry, RR
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (09): : 1171 - 1179
  • [25] Role of Insulin-like Growth Factor-1 in the Regulation of Skeletal Growth
    Subburaman Mohan
    Chandrasekhar Kesavan
    Current Osteoporosis Reports, 2012, 10 : 178 - 186
  • [26] Growth hormone, insulin-like growth factor-1 and the aging brain
    Ashpole, Nicole M.
    Sanders, Jessica E.
    Hodges, Erik L.
    Yan, Han
    Sonntag, William E.
    EXPERIMENTAL GERONTOLOGY, 2015, 68 : 76 - 81
  • [27] Role of Insulin-like Growth Factor-1 in the Regulation of Skeletal Growth
    Mohan, Subburaman
    Kesavan, Chandrasekhar
    CURRENT OSTEOPOROSIS REPORTS, 2012, 10 (02) : 178 - 186
  • [28] Insulin-Like Growth Factor Pathway
    Haluska, Paul
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S478 - S479
  • [29] Association of insulin-like growth factor-1 with thyroid nodules
    Liu, Ying-Jian
    Qiang, Wei
    Liu, Xing-Jun
    Xu, Li
    Guo, Hui
    Wu, Li-Ping
    Shi, Bingyin
    ONCOLOGY LETTERS, 2011, 2 (06) : 1297 - 1301
  • [30] The complex biology of the receptor for the insulin-like growth factor-1
    Romano, G
    DRUG NEWS & PERSPECTIVES, 2003, 16 (08) : 525 - 531